| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $5.0M | +19.0% |
| Cost of Revenue | $1.8M | +15.5% |
| Gross Profit | $3.3M | +20.9% |
| R&D Expense | $2.4M | +20.3% |
| SG&A Expense | $17.5M | +171.6% |
| Operating Income | -$17.9M | -153.7% |
| Pre-tax Income | -$15.8M | -102.6% |
| Income Tax | $12K | -96.2% |
| Net Income | -$15.8M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $193.6M | +1229.3% |
| Short-term Investments | $58.3M | +265.8% |
| Accounts Receivable | $1.8M | +31.0% |
| Inventory | $1.4M | +20.2% |
| Current Assets | $255.5M | +673.2% |
| Total Assets | $272.8M | +539.5% |
| Current Liabilities | $2.4M | +422.6% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.0M | -78.7% |
| Capital Expenditures | $5.0M | +590.9% |
| Investing Cash Flow | -$48.0M | -111.1% |
| Financing Cash Flow | $236.1M | +463.2% |
| Free Cash Flow | -$14.1M | -142.9% |
| -93.5% |
| EPS (Basic) | -$0.13 | -8.3% |
| EPS (Diluted) | -$0.13 | -8.3% |
| Total Liabilities |
| $2.9M |
| +220.4% |
| Stockholders' Equity | $269.9M | +546.6% |